Clearmind Medicine Prices $1.60 Registered Direct Offering & Private Placement
Ticker: CMND · Form: 6-K · Filed: Jan 16, 2024 · CIK: 1892500
Complexity: simple
Sentiment: mixed
Topics: capital-raise, direct-offering, private-placement, warrants
TL;DR
**CMND is raising capital through a direct offering and private placement at $1.60 per share, expect potential dilution.**
AI Summary
Clearmind Medicine Inc. (CMND) announced on January 16, 2024, the pricing of a registered direct offering and concurrent private placement. The company will sell 1,468,000 common shares and pre-funded warrants for 32,000 common shares, along with 1,500,000 common warrants (PIPE Warrants) to the same investors. The offering price for a common share and associated PIPE Warrant is $1.60, while a pre-funded warrant and associated PIPE Warrant is $1.5999. This matters to investors because it indicates the company is raising capital, which could dilute existing shareholders but also fund future operations and research.
Why It Matters
This capital raise provides Clearmind Medicine with funds for operations but could dilute the ownership stake of current shareholders due to the issuance of new shares and warrants.
Risk Assessment
Risk Level: medium — The offering involves issuing new shares and warrants, which can dilute existing shareholder value, but the capital raised could also reduce immediate financial risk.
Analyst Insight
Investors should monitor the company's use of the newly raised capital and assess the potential for dilution against the benefits of funding future projects. Consider the impact of new shares and warrants on per-share value.
Key Numbers
- 1,468,000 — Common Shares (Number of common shares sold in the Registered Direct Offering.)
- 32,000 — Pre-Funded Warrants (Number of common shares purchasable via Pre-Funded Warrants.)
- 1,500,000 — PIPE Warrants (Number of common warrants issued in the concurrent Private Placement.)
- $1.60 — Offering Price (Price per Ordinary Share and associated PIPE Warrant.)
- $0.0001 — Pre-Funded Warrant Exercise Price (Exercise price for the Pre-Funded Warrants.)
Key Players & Entities
- Clearmind Medicine Inc. (company) — the registrant issuing securities
- 1,468,000 (dollar_amount) — number of common shares sold in the registered direct offering
- 32,000 (dollar_amount) — number of common shares underlying pre-funded warrants
- 1,500,000 (dollar_amount) — number of common warrants (PIPE Warrants) issued in the private placement
- $1.60 (dollar_amount) — offering price per ordinary share and associated PIPE Warrant
- $1.5999 (dollar_amount) — offering price per pre-funded warrant and associated PIPE Warrant
- January 11, 2024 (date) — date the securities purchase agreement was entered into
- January 16, 2024 (date) — expected closing date of the offerings
Forward-Looking Statements
- Clearmind Medicine Inc. will successfully close the offerings as planned. (Clearmind Medicine Inc.) — high confidence, target: January 16, 2024
- The capital raised will be primarily used to advance the company's pharmaceutical preparations. (Clearmind Medicine Inc.) — medium confidence, target: Q1 2025
FAQ
What is the total number of common shares and shares underlying pre-funded warrants being offered in the Registered Direct Offering?
Clearmind Medicine Inc. is offering 1,468,000 common shares and pre-funded warrants to purchase up to 32,000 common shares in the Registered Direct Offering, totaling 1,500,000 shares/share equivalents.
What is the exercise price and term for the PIPE Warrants issued in the concurrent private placement?
The PIPE Warrants will be exercisable upon issuance at an exercise price of $1.60 per share and will have a 5-year term from the issuance date.
What is the offering price for a Pre-Funded Warrant and its associated PIPE Warrant?
The offering price for a Pre-Funded Warrant and its associated PIPE Warrant is $1.5999.
When is the Registered Direct Offering and concurrent Private Placement expected to close?
The Registered Direct Offering and concurrent Private Placement are expected to close on or about January 16, 2024.
What is the exercise price and expiration for the Pre-Funded Warrants?
The Pre-Funded Warrants will be immediately exercisable at an exercise price of $0.0001 per Common Share and will not expire until exercised in full.
Filing Stats: 1,171 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2024-01-16 09:26:37
Key Financial Figures
- $0.0001 — ely exercisable at an exercise price of $0.0001 per Common Share and will not expire un
- $1.60 — e upon issuance at an exercise price of $1.60 per share and will have a 5-year term f
- $1.5999 — Warrant and associated PIPE Warrant is $1.5999. The Offerings are expected to close on
- $2.4 million — ctions are expected to be approximately $2.4 million. In connection with the Securities Pur
- $75,000 — d in the Registered Direct Offering and $75,000 for reasonable legal fees and disbursem
Filing Documents
- ea191615-6k_clearmind.htm (6-K) — 23KB
- ea191615ex5-1_clearmind.htm (EX-5.1) — 21KB
- ea191615ex5-2_clearmind.htm (EX-5.2) — 13KB
- ea191615ex10-1_clearmind.htm (EX-10.1) — 250KB
- ea191615ex10-2_clearmind.htm (EX-10.2) — 128KB
- ea191615ex10-3_clearmind.htm (EX-10.3) — 103KB
- ea191615ex10-4_clearmind.htm (EX-10.4) — 155KB
- ea191615ex10-5_clearmind.htm (EX-10.5) — 74KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- ex5-1_002.jpg (GRAPHIC) — 1KB
- ex5-2_001.jpg (GRAPHIC) — 3KB
- ex10-5_001.jpg (GRAPHIC) — 12KB
- ex10-5_002.jpg (GRAPHIC) — 2KB
- 0001213900-24-003558.txt ( ) — 797KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Clearmind Medicine, Inc. (Registrant) Date: January 16, 2024 By: /s/ Adi Zuloff-Shani Name: Adi Zuloff-Shani Title: Chief Executive Officer 4